The new OPTN kidney allocation policy: Potential for inequitable access among highly sensitized patients

American Journal of Transplantation

Volumn 15, Issue 1, 2015, Pages 284-285

  Bray, R A ^a   Brannon, P ^a   Breitenbach, C ^b   Bryan, C ^c   Chen, D F ^d   Lai, J ^e   McRacken, T ^f   Kirk, A ^d   Kaplan, B ^g   Pearson, T ^h   Gebel, H M ^a  

^a EMORY UNIVERSITY HOSPITAL   (United States)

^b Henrico Doctor's Hospital   (United States)

^c Midwest Transplant Network   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^f SENTARA NORFOLK GENERAL HOSPITAL   (United States)

^g UNIVERSITY OF KANSAS   (United States)

^h EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DPB1 ANTIGEN; HLA DQA1 ANTIGEN;

GRAFT RECIPIENT; HEALTH CARE ACCESS; HEALTH CARE POLICY; HOSPITAL ADMISSION; HUMAN; KIDNEY ALLOGRAFT; KIDNEY DONOR; LETTER; DONOR; HISTOCOMPATIBILITY; IMMUNOLOGY; LEGISLATION AND JURISPRUDENCE; PATIENT ATTITUDE; PROGNOSIS; RESOURCE ALLOCATION; SUPPLY AND DISTRIBUTION; TRANSPLANTATION;

HEALTH POLICY; HISTOCOMPATIBILITY; HUMANS; PATIENT ACCEPTANCE OF HEALTH CARE; PROGNOSIS; RESOURCE ALLOCATION; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; WAITING LISTS;

EID: 84919846487     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13061     Document Type: Letter

References (6)

1. Cecka JM, Kucheryavaya AY, Reinsmoen NL, Leffell MS., Calculated PRA: Initial results show benefits for sensitized patients and a reduction in positive crossmatches. Am J Transplant 2011; 4: 719-724.
2. Arnold ML, Pei R, Spriewald B, Wassmuth R., Anti-HLA class II antibodies in kidney retransplant patients. Tissue Antigens 2005; 65: 370-378.
3. Duquesnoy RJ, Awadalla Y, Lomago J, et al. Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR,DQ,DP epitopes. Transpl Immunol 2008; 18: 352-360.
4. Billen EV, Christiaans MH, Doxiadis II, Voorter CE, van den Berg-Loonen EM., HLA-DP antibodies before and after renal transplantation. Tissue Antigens 2010; 75: 278-285.
5. Tambur AR, Leventhal JR, Zitzner JR, Walsh RC, Friedewald JJ., The DQ barrier: Improving organ allocation equity using HLA-DQ information. Transplantation 2013; 95: 635-640.
6. Kucheryavaya A, Tyan D, Boyle G, Kiger D, Murphey C, Baxter-Lowe L., A substantial increase in reporting of HLA-DPB typing of deceased donors in the U.S. Am J Transplant 2014; 14: 590.